L&C Professional Medical Research Institute

Miami, Florida 33186

1 studies enrolling now · 15 studies all time

What they study most

Acute Bacterial Skin and Skin Structure Infections, Alopecia Areata, Alpha1-antitrypsin Deficiency, Alzheimer Disease, Arthritis, Rheumatoid, Atopic Dermatitis, COVID-19, Cardiovascular Diseases, Chronic Kidney Disease, Chronic Obstructive Pulmonary Disease, Mild Cognitive Impairment, Obesity

Studies at this site

• Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata — Recruiting now
• A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk — Completed
• A Study of Health Care Use and Costs in Participants With Early Stage Alzheimer's Disease (AD) — Running, not enrolling
• Evaluation of Efficacy and Safety of VX-548 for Painful Lumbosacral Radiculopathy (PLSR) — Completed
• A Study of Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, in Participants With Obesity or Overweight With Type 2 Diabetes — Withdrawn before enrolling
• Safety and Efficacy of TRx0237 in Subjects With Alzheimer's Disease Followed by Open-Label Treatment — Completed
• PK and Safety Study of Natroba Topical Suspension 0.9% in Subjects 1 Month to 3 Years 11 Months of Age With Scabies — Status unconfirmed
• Abrocitinib Expanded Access Protocol in Adolescents and Adults With Moderate to Severe Atopic Dermatitis — NO_LONGER_AVAILABLE
• Ceftobiprole in the Treatment of Patients With Acute Bacterial Skin and Skin Structure Infections — Completed
• Study in Participants With Early Stage Coronavirus Disease 2019 (COVID-19) to Evaluate the Safety, Efficacy, and Pharmacokinetics of Remdesivir Administered by Inhalation — Completed
• Study to Evaluate the Efficacy and Safety of Remdesivir (GS-5734™) Treatment of Coronavirus Disease 2019 (COVID-19) in an Outpatient Setting — Stopped early
• Phase 3 Trial to Assess the Safety and Efficacy of Natroba for the Treatment of Scabies — Completed
• Stage 1 Study of ARALAST NP and GLASSIA in A1PI Deficiency — Stopped early
• Long-term Assessment of Safety and Efficacy of BI 695501 in Patients With Rheumatoid Arthritis — Completed
• A Study to Evaluate the Therapeutic Equivalence of Generic Permethrin Cream 5% to Elimite® in the Treatment of Scabies — Completed